EV3 and FoxHollow Merger Establishes Peripheral Leader
Executive Summary
FoxHollow's striking success in peripheral vascular disease was not lost on EV3, which, like FoxHollow, abandoned earlier efforts in coronaries to focus exclusively on peripherals. Now the companies are merging to form what is surely the biggest vascular device company dedicated to the peripheral market. (Sidebar to, "EV3/Novation: Can Group Contracting Work in High Tech?")